PET-based Biomarkers in cancer

Positron-emission tomography (PET) is an imaging technique allowing tumor metabolism to be visualized. PET images provide a spatial distribution of the active tumor cells. We use these images to compute quantitative measures and correlate them with clinical data, specifically in breast cancer, brain tumors and other tumor types. The goal is to define PET-based biomarkers of tumor aggressiveness and response to therapies of utility in breast cancer management.